Vancouver, Canada

Anthony A Shaw

This inventor holds 2 USPTO granted patents, plus 5 CIPO patents and 1 EPO patent. Top assignees: Universitè Laval, Arna Therapeutics Inc., Imstar Therapeutics Inc.. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anthony A Shaw. Retrieved from https://idiyas.com/inventor/anthony-a-shaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anthony A Shaw: Innovator in Neurodegenerative Disease Treatment

Introduction

Anthony A Shaw is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, his work focuses on the development of synthetic analogs of withanolide natural products.

Latest Patents

Shaw's latest patents include innovative formulations that utilize withanolides for therapeutic purposes. One of his patents details synthetic analogs of withanolide natural products and their pharmaceutical applications in treating neurodegenerative diseases. Another patent similarly outlines synthetic analogs of withanolides, emphasizing their potential in addressing neurodegenerative conditions.

Career Highlights

Throughout his career, Anthony A Shaw has worked with esteemed organizations such as Université Laval and Arna Therapeutics Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Shaw has collaborated with notable colleagues, including Jean-Pierre Julien and Agnes H Chan. These partnerships have enriched his research endeavors and fostered innovation in his field.

Conclusion

Anthony A Shaw's work in developing treatments for neurodegenerative diseases through withanolides showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against these challenging conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…